Uncategorized

  • Vanderbilt University

    Nikon Center of Excellence for live-cell imaging makes debut

    Officials of Vanderbilt University, Vanderbilt University Medical Center (VUMC) and Nikon Instruments Inc. celebrated the opening of the Vanderbilt Nikon Center of Excellence, which features state-of-the-art microscopy for live-cell imaging. Read More

    Oct. 13, 2016

  • Vanderbilt University

    David Sweatt studies how brain chemistry affects learning and memory

    Homecoming came early this year for Vanderbilt alumnus David Sweatt, who joined the faculty as chair of Pharmacology this summer, 30 years after receiving his Ph.D. from the department he now leads. Read More

    Oct. 13, 2016

  • Vanderbilt University

    Basic Science, Extraordinary Impact

    The discoveries that can change the course of human health forever often begin in the tiniest places: in molecules and cells, at the most fundamental intersection of physics, chemistry and biology. What makes a gene misfire? How do nerves talk to each other? What makes a cell resist one chemical… Read More

    Oct. 7, 2016

  • Vanderbilt University

    2016 Middleton Award recipient! Dr. Richmond

    Ann Richmond, Ph.D. is one of two recipients of the 2016 William S. Middleton Award.  This award is the Veterans Health Administration Biomedical Laboratory Research & Development's highest honor for outstanding achievement in biomedical research.  The award recognizes Dr. Richmond’s exemplary record of involvement in, and… Read More

    Sep. 30, 2016

  • Vanderbilt University

    Researchers eye potential schizophrenia ‘switch’

    Researchers at Vanderbilt University Medical Center have discovered a key mechanism that explains how compounds they’re developing can suppress schizophrenia-like symptoms in mice without side effects. On the basis of this discovery, reported this month in the journal Neuron, “we now have much stronger understanding of the therapeutic potential… Read More

    Sep. 22, 2016

  • Vanderbilt University

    Study reveals new clues to cystic fibrosis ‘gender gap’

    A research team led by structural biologists from Vanderbilt University has come up with the first detailed molecular explanation for a factor that may contribute to the so-called cystic fibrosis (CF) “gender gap.” There is evidence that women with CF die on average two to three years earlier… Read More

    Sep. 22, 2016

  • Vanderbilt University

    New fund honors spirit of Cohen’s innovative research

    When Tom Daniel, M.D., joined the Vanderbilt University faculty in December 1986, Stanley Cohen, Ph.D., had just been awarded the Nobel Prize in Physiology or Medicine for his discovery of epidermal growth factor (EGF). “Stanley was part of the reason I came to Vanderbilt,” said Daniel, who recently retired as… Read More

    Aug. 25, 2016

  • Vanderbilt University

    Program helps Ph.D. students find non-academic careers

    In 2013, Vanderbilt University School of Medicine (VUSM) received one of 10 grants from the National Institutes of Health called BEST (Broadening Experiences in Scientific Training) to help train scientists for a variety of diverse careers. The program grew from a workforce study indicating that 80 percent of people with biomedical… Read More

    Aug. 18, 2016

  • Vanderbilt University

    New center will examine addiction at molecular level, develop treatments

    Vanderbilt University researchers from diverse scientific disciplines are joining forces to help crack the stubborn mysteries of addiction. Through the new Vanderbilt Center for Addiction Research (VCAR), their goal is to define the molecular events that drive addictive behavior and, ultimately, to develop new treatments that can help people sustain long-term recovery. “Addiction… Read More

    Aug. 17, 2016

  • Vanderbilt University

    Foundation’s support speeds search for new schizophrenia drugs at Vanderbilt

    Research in the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD) aimed at developing innovative new treatments for schizophrenia just received a powerful assist from The William K. Warren Foundation.  The Tulsa, Oklahoma-based foundation announced it will increase its support by another $1 million, as VCNDD’s game-changing schizophrenia program approaches the point… Read More

    Aug. 15, 2016